FOLFIRINOX May Be Feasible in Select Elderly Patients With PDAC | Targeted Oncology

A new observational study in the Journal of Clinical Oncology – Oncology Practice provides real-world evidence demonstrating feasibility of 5-fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFIRINOX; FFX) chemotherapy in carefully…

Continue Reading